A carregar...
Apatinib enhances chemosensitivity of gastric cancer to paclitaxel and 5-fluorouracil
Background and aim: Paclitaxel (PTX) plus 5-fluorouracil (5-Fu) has become the standard chemotherapy for advanced gastric cancer (GC). Apatinib, a small-molecule tyrosine kinase inhibitor targeting vascular endothelial growth factor receptor-2, improves outcomes in GC patients as a third-line treatm...
Na minha lista:
| Publicado no: | Cancer Manag Res |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6549793/ https://ncbi.nlm.nih.gov/pubmed/31213909 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CMAR.S196372 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|